Please login to the form below

Not currently logged in
Email:
Password:

genomic medicine

This page shows the latest genomic medicine news and features for those working in and with pharma, biotech and healthcare.

First patient treated with Sangamo’s gene-editing tech

First patient treated with Sangamo’s gene-editing tech

The firm’s CEO, Sandy Macrae, says the first dosing means “we are at the start of a new frontier of genomic medicine”.

Latest news

  • Roche buys gene sequencing firm Roche buys gene sequencing firm

    after it took a majority stake in genomic analysis specialist Foundation Medicine Inc for $1.18bn. ... Wilmington, Massachusetts-based Kapa is a protein engineering specialist, making enzymes and other reagents used in genomic studies that can help

  • Think big, not small Think big, not small

    The Global Alliance for Genomics and Health is looking into improving genomic medicine through more effective data sharing, while TransCelerate BioPharma approaches R&D innovation from the perspective of those carrying

  • Nurturing innovation in a tough environment Nurturing innovation in a tough environment

    Freeman said the government's aim is to make the NHS the first mainstream health system in the world that offers genomic medicine as part of routine care for its patients. ... Freeman described the £300m project as the “ NASA of genomic medicine”

  • AstraZeneca joins Genomics England consortium AstraZeneca joins Genomics England consortium

    The GENE Consortium (Genomics Network for Enterprises Consortium) is a unique partnership between industry, academia and the NHS Genomic Medicine Centres.

  • DNA expert: use genes to assess disease risk DNA expert: use genes to assess disease risk

    There is increasing momentum to use genomic sequencing as part of routine care, however, with NHS England currently involved in a project to sequence the genomes of 100, 000 people with ... The UK's minister for life sciences George Freeman is behind the

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • Medical affairs Medical affairs

    Personalised medicine strategies using targeted approaches are being developed to achieve the best outcomes in the management of a patient’s disease or predisposition to disease. ... analysis of ‘big data’, genomic and proteomic diagnosis and

  • A rare opportunity A rare opportunity

    Meanwhile, the 100, 000 Genomes Project is making strong progress in the creation of a new genomic medicine service for the NHS and, more recently, political momentum has been building in

  • Pharma deals during January 2013 Pharma deals during January 2013

    for Genomic Medicine.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Editas Medicine names James Mullen as chairman Editas Medicine names James Mullen as chairman

    Editas Medicine names James Mullen as chairman. He has previously served as CEO of Patheon. ... Jim’s extensive experience in driving excellence across R&D, commercialisation, manufacturing, business development and capital formation will be invaluable

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Big data, privacy and the rise of genomic testing

    Genomic sequencers generate enormous amounts of data so we are still scratching the surface. ... The whole personalised medicine trend is very powerful but sharing genomic information is just the start,” says Johan. “

  • Perspective on biotech leaders

    The patient-centric heart of the industry. The changing role of medical information in precision medicine. ... The future of clinical diagnostics and liquid biopsy. Big data, privacy and the rise of genomic testing.

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics